GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (XTER:DC4) » Definitions » Net Income From Continuing Operations

DexCom (XTER:DC4) Net Income From Continuing Operations : €590 Mil (TTM As of Mar. 2024)


View and export this data going back to 1990. Start your Free Trial

What is DexCom Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. DexCom's net income from continuing operations for the three months ended in Mar. 2024 was €135 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was €590 Mil.

DexCom Net Income From Continuing Operations Historical Data

The historical data trend for DexCom's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Net Income From Continuing Operations Chart

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 90.99 405.74 191.96 322.09 496.56

DexCom Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.39 106.98 113.10 235.03 134.69

DexCom Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €590 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexCom (XTER:DC4) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (XTER:DC4) » Definitions » Net Income From Continuing Operations
Comparable Companies
EW ZBH ALGN STE SWAV BRKR PODD PEN BIO MASI ABT SYK BSX MDT XTER:SHL SZSE:300760 XAMS:PHIA XSWX:SOON SHSE:688271 ASX:COH
Traded in Other Exchanges
DXCM:USA DXCM:Mexico D1EX34:Brazil DXCM:Austria
Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Website
https://www.dexcom.com
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

DexCom (XTER:DC4) Headlines

No Headlines